In Israel's largest acquisition, Teva buys Allergan Generics for $40.5b
Deal will further enhance Teva’s goals of delivering the highest quality medicines at the most competitive prices, Israeli company says.
Teva Pharmaceutical Industries building in Jerusalem.(photo credit: MARC ISRAEL SELLEM/THE JERUSALEM POST)Updated: